diet plans

2022 Census Data Published: Commercial Weight Loss Industry Statistics

April 24, 2025 The U.S. Census of Service Industries is performed every 5 years, with the last government survey performed in 2022. Commercial weight loss companies (“diet & reducing centers”) are classified under NAICS code 812191 (other personal services). Establishment and firms data for this industry have just been released (see census.gov). This information is […]

2022 Census Data Published: Commercial Weight Loss Industry Statistics Read More »

Novo Nordisk Submits Weight Loss Pill for FDA Approval

News / John LaRosa

April 24, 2025 Novo Nordisk asked the Food and Drug Administration to approve a pill version of its popular weight loss drug in obesity earlier this year, a spokesperson confirmed. The company first reported in 2023 that the drug, an oral form of semaglutide, succeeded in a Phase 3 trial, helping people on the highest

Novo Nordisk Submits Weight Loss Pill for FDA Approval Read More »

$5 Billion U.S. Meal Replacements Market Survives GLP-1s Competition

News / John LaRosa

April 22, 2025 Marketdata LLC has just released a new market study: “The U.S. Meal Replacements Market: Retail & MLM Channels”, April 2025. This 77-page report analyses the meal replacements and retail appetite suppressants market in the U.S. The $5.1 billion U.S. meal replacements market has held up fairly well the past few years, despite

$5 Billion U.S. Meal Replacements Market Survives GLP-1s Competition Read More »

Eli Lilly’s New Weight Loss Pill Shows Promise

News / John LaRosa

April 17, 2025 New research released Thursday morning shows a new, oral GLP-1 pill may be just as beneficial to those with Type 2 diabetes as injectable GLP-1 drugs. Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce hemoglobin A1C levels on average by 1.3-1.6%

Eli Lilly’s New Weight Loss Pill Shows Promise Read More »

Gyms Start Selling GLP-1 Drugs? The Bandwagon Gets More Crowded

News / John LaRosa

April 12, 2025 We noticed a post on Instagram today that pitches a company that will set up a medical weight loss program, using GLP-1 drugs for gyms. We shouldn’t be surprised. Everyone else has entered the GLP-1 gold rush, including med spas, so why not gyms as well? The company offering this “opportunity” is

Gyms Start Selling GLP-1 Drugs? The Bandwagon Gets More Crowded Read More »

Weight Watchers Prepares for Possible Bankruptcy Filing

News / John LaRosa

April 9, 2025 (Reuters) – WW International may be preparing to file for bankruptcy in the coming months as part of a plan to hand control of the business to its creditors, the Wall Street Journal reported on Wednesday, citing people familiar with the matter. Shares of the company tumbled nearly 59% to 18 cents

Weight Watchers Prepares for Possible Bankruptcy Filing Read More »

Weight Watchers Investor Seeks Board Seats

News / John LaRosa

April 3, 2025 Premca Capital, an investment fund, has nominated three directors for election to WW International’s board, according to the people familiar with the matter. WW has a market capitalization of about $40 million, following a sharp decline in its shares in recent years. Its stock is down nearly 70% in the past year, due

Weight Watchers Investor Seeks Board Seats Read More »

Robard Begins Selling Diet Foods Direct to Consumers

News / John LaRosa

April 2, 2025 Robard, the medical weight loss company, has begun selling its shakes, puddings, soups and beverages direct to the public via a new website. These products are part of its New Direction program. This is a departure from its long-standing policy where you had to sign up for the program to get access

Robard Begins Selling Diet Foods Direct to Consumers Read More »

A Recession Is NOT The Time To Cut Marketing

News / John LaRosa

March 31, 2025 Many economists and analysts are saying that a recession is coming sometime this year. That said, many weight loss companies and their top managers will say they’ll have to cut expenses, especially marketing. That’s the knee-jerk reaction, but it’s dead wrong. When consumers cut back on spending, they will revert to trusted

A Recession Is NOT The Time To Cut Marketing Read More »

$38.4 Billion U.S. Commercial Weight Loss Market Pivots To Survive GLP-1 Drugs Explosion

News / John LaRosa

March 24, 2025 Marketdata LLC has just published a new report: “The U.S. Weight Loss Market: Commercial (non-medical) Programs & Products”, March 2025. This is a 220-page analysis of commercial weight loss programs/companies and how they have been affected by and respond to the onslaught of the GLP-1 drugs competition. The $38 billion U.S. commercial weight loss

$38.4 Billion U.S. Commercial Weight Loss Market Pivots To Survive GLP-1 Drugs Explosion Read More »

(813) 971-8080